Brief: ICU Medical Q4 Adjusted EPS USD 2.11 Vs. IBES Estimate USD 1.48
Feb 27 (Reuters) - ICU Medical Q4 revenue USD 629.805 million vs. IBES estimate USD 596.6 million. Q4 gross profit USD 227.258 million Q4 gross margin 36.1% Q4 adjusted EBITDA USD 105.5 million vs. IBES estimate USD 95.4 million
Recent news on ICU Medical
See all newsU.S. RESEARCH ROUNDUP-Airbnb, Expedia Group, Parker-Hannifin
ICU Medical, Inc. reports results for the quarter ended June 30 - Earnings Summary
ICU Medical Q2 revenue beat estimates on strength in Infusion Systems
Brief: ICU Medical Q2 Adjusted EPS USD 2.37 Vs. IBES Estimate USD 1.91
U.S. RESEARCH ROUNDUP: Airbnb, Doordash, Zillow Group